Previously an outspoken critic of AI actress Tilly Norwood, Blunt shared that she was ‘terrified’ to rely on generative tech ...
Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes.